Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 7/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | RECQL | P46063 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | POLB | P06746 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 1.00 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 1.00 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 1.00 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 1.00 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 1.00 |
| ▸ | PTGES | O14684 | 4/20 | 0.59 |
| ▸ | KIF20B | Q96Q89 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
| ▸ | CENPE | Q02224 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lobaric Acid SCHEMBL29431924 | 1.00 | PTPN1 (1.00) | PTPN1MAPTRECQLMEN1KMT2A | |
| Lobaric Acid SCHEMBL29788372 | 1.00 | PTPN1 (1.00) | PTPN1MAPTRECQLMEN1KMT2A | |
| SCHEMBL14703230 | 0.96 | PTPN1 (0.93) | PTPN1MAPTRECQLMEN1KMT2A | |
| SCHEMBL15294483 | 0.89 | PTPN1 (0.80) | PTPN1MAPTRECQLMEN1KMT2A | |
| SCHEMBL15178484 | 0.89 | PTPN1 (0.80) | PTPN1MAPTRECQLMEN1KMT2A | |
| SCHEMBL30059040 | 0.87 | PTPN1 (0.77) | PTPN1MAPTRECQLMEN1KMT2A | |
| SCHEMBL17988184 | 0.82 | MAPT (1.00) | PTPN1MAPTRECQLMEN1KMT2A | |
| SCHEMBL15294481 | 0.81 | PTPN1 (0.69) | PTPN1MAPTRECQLMEN1KMT2A | |
| SCHEMBL17975293 | 0.81 | PTPN1 (0.67) | PTPN1MAPTRECQLMEN1KMT2A | |
| SCHEMBL17988185 | 0.76 | MAPT (0.77) | PTPN1MAPTRECQLMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11434217-B2 | Method for synthesis of lobaric acid and analog thereof | KOREA INSTITUTE OF OCEAN SCIENCE AND TECHNOLOGY (KR) | 2022-09-06 | — | — | US | disclosed |
| US-20210246112-A1 | METHOD FOR SYNTHESIS OF LOBARIC ACID AND ANALOG THEREOF | KOREA INSTITUTE OF OCEAN SCIENCE AND TECHNOLOGY (KR) | 2021-08-12 | — | — | US | disclosed |
| US-20160220510-A1 | ANTIBIOTIC COMPOUNDS THAT INHIBIT BACTERIAL PROTEIN SYNTHESIS | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2016-08-04 | — | — | US | disclosed |
| US-8846750-B2 | Pharmaceutical and food compositions for preventing or treating diabetes or obesity | KOREA OCEAN RESEARCH AND DEVELOPMENT INSTITUTE (KR) | 2014-09-30 | — | — | US | disclosed |
| US-20140073614-A1 | PHARMACEUTICAL AND FOOD COMPOSITIONS FOR PREVENTING OR TREATING DIABETES OR OBESITY | KOREA OCEAN RESEARCH AND DEVELOPMENT INSTITUTE (KR) | 2014-03-13 | — | — | US | disclosed |
| US-20130261174-A1 | PHARMACEUTICAL AND FOOD COMPOSITIONS FOR PREVENTING OR TREATING DIABETES OR OBESITY | KOREA OCEAN RESEARCH AND DEVELOPMENT INSTITUTE (KR) | 2013-10-03 | — | — | US | disclosed |
| EP-2626070-A2 | PHARMACEUTICAL AND FOOD COMPOSITION FOR PREVENTING OR TREATING DIABETES OR OBESITY | Korea Ocean Research And Development Insitute (KR) | 2013-08-14 | — | — | EP | disclosed |
| US-20090048332-A1 | Natural Novel Antioxidants | HEJ RESEARCH INSITUTE (PK) | 2009-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140073614-A1 | PHARMACEUTICAL AND FOOD COMPOSITIONS FOR PREVENTING OR TREATING DIABETES OR OBESITY | PTPRC, PPP5C, PPM1B | PTPN1 11/4885MAPT 2258/4885RECQL 4485/4885 |
| US-20130261174-A1 | PHARMACEUTICAL AND FOOD COMPOSITIONS FOR PREVENTING OR TREATING DIABETES OR OBESITY | PTPRC, PPP5C, PPM1B | PTPN1 11/4885MAPT 2258/4885RECQL 4485/4885 |
| US-20160220510-A1 | ANTIBIOTIC COMPOUNDS THAT INHIBIT BACTERIAL PROTEIN SYNTHESIS | AARS1, EPRS1, EEF1G | PTPN1 1794/4885MAPT 1595/4885RECQL 2796/4885 |
| US-20210246112-A1 | METHOD FOR SYNTHESIS OF LOBARIC ACID AND ANALOG THEREOF | PPP6C, PPP4C, PPP3CB | PTPN1 129/4885MAPT 948/4885RECQL 4705/4885 |
| US-11434217-B2 | Method for synthesis of lobaric acid and analog thereof | PPP6C, PPP4C, PPP3CB | PTPN1 129/4885MAPT 948/4885RECQL 4705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.